Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery

Elective Cardiac Surgery Clinical Trial

Official title:
Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) Versus Albumin Solution for Volume Replacement in Patients After Cardiac Surgery

Status Not yet recruiting

Clinical Trial Summary

The purpose of this randomized controlled trial in patients undergoing cardiac surgery is to show that a 3rd generation HES (Hydroxyethyl Starch) solution - Tetraspan® is as good as in terms of safety and effectiveness as the commonly used albumin based solution for volume replacement after the surgery.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Elective Cardiac Surgery

Clinical Trial Details

NCT number	NCT01418521
Study type	Interventional
Source	Rambam Health Care Campus
Contact	Liran Shani, MD
Phone	972-8542631
Email	l_shani@rambam.health.gov.il
Status	Not yet recruiting
Phase	Phase 4
Start date	August 2011
Completion date	August 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02838524` - Acceptable Range of Inspiratory Effort During Mechanical Ventilation
Completed	`NCT02566525` - CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery	N/A
Completed	`NCT00879931` - Influence of Corticoids on Renal Function in Cardiac Surgery	Phase 2
Recruiting	`NCT05662501` - Pleiades Safety and Feasibility Study	N/A
Completed	`NCT02407873` - Prognostic Impact of Frailty Assessed by Edmondon in Elderly Patient Undergoing Cardiac Surgery	N/A
Completed	`NCT01748266` - Microcirculation of the Thenar Eminence	N/A
Terminated	`NCT03384875` - CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery	N/A